| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4024201 | Journal Français d'Ophtalmologie | 2012 | 6 Pages |
Abstract
Intravitreal bevacizumab is useful as a surgical additive in severe cases of PDR, significantly improving surgical conditions. Nevertheless, its use beyond approved indications should be reserved for complex surgical cases.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
A. Couzinet, S. Auriol, L. Lequeux, J.-L. Arné, V. Pagot-Mathis,